In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike protein

dc.contributor.authorMurugesan, Sankaranarayanan
dc.contributor.authorDeepa, P. R.
dc.contributor.authorGarg, Mohit
dc.date.accessioned2023-12-07T15:22:41Z
dc.date.available2023-12-07T15:22:41Z
dc.date.issued2023-07
dc.description.abstractNovel nature of the viral pathogen SARS-CoV-2 and the absence of standard drugs for treatment, have been a major challenge to combat this deadly infection. Natural products offer safe and effective remedy, for which traditional ethnic medicine can provide leads. An indigenous poly-herbal formulation, Kabasura Kudineer from Siddha system of medicine was evaluated here using a combination of computational approaches, to identify potential inhibitors against two anti-SARS-CoV-2 targets – post-fusion Spike protein (structural protein) and main protease (Mpro, non-structural protein).en_US
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2225411023000809?via%3Dihub
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13319
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacyen_US
dc.subjectIddha medicineen_US
dc.subjectKabasura kudineeren_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjectMolecular dockingen_US
dc.subjectPost fusion spike proteinen_US
dc.titleIn silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike proteinen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: